BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 26882981)

  • 1. Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis - A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease.
    Kohanim S; Palioura S; Saeed HN; Akpek EK; Amescua G; Basu S; Blomquist PH; Bouchard CS; Dart JK; Gai X; Gomes JA; Gregory DG; Iyer G; Jacobs DS; Johnson AJ; Kinoshita S; Mantagos IS; Mehta JS; Perez VL; Pflugfelder SC; Sangwan VS; Sippel KC; Sotozono C; Srinivasan B; Tan DT; Tandon R; Tseng SC; Ueta M; Chodosh J
    Ocul Surf; 2016 Apr; 14(2):168-88. PubMed ID: 26882981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis--A Comprehensive Review and Guide to Therapy. I. Systemic Disease.
    Kohanim S; Palioura S; Saeed HN; Akpek EK; Amescua G; Basu S; Blomquist PH; Bouchard CS; Dart JK; Gai X; Gomes JA; Gregory DG; Iyer G; Jacobs DS; Johnson AJ; Kinoshita S; Mantagos IS; Mehta JS; Perez VL; Pflugfelder SC; Sangwan VS; Sippel KC; Sotozono C; Srinivasan B; Tan DT; Tandon R; Tseng SC; Ueta M; Chodosh J
    Ocul Surf; 2016 Jan; 14(1):2-19. PubMed ID: 26549248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study.
    Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK
    BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications.
    Ueta M
    Expert Rev Clin Immunol; 2020 Mar; 16(3):285-291. PubMed ID: 32045311
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Hasegawa A; Abe R
    F1000Res; 2020; 9():. PubMed ID: 32595945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmic Aspects of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Narrative Review.
    Tóth G; Lukács A; Schirra F; Sándor GL; Killik P; Maneschg OA; Nagy ZZ; Szentmáry N
    Ophthalmol Ther; 2023 Aug; 12(4):1795-1811. PubMed ID: 37140876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular manifestations of Stevens-Johnson syndrome and their management.
    Saeed HN; Chodosh J
    Curr Opin Ophthalmol; 2016 Nov; 27(6):522-529. PubMed ID: 27585215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
    Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS
    Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Van Batavia JP; Chu DI; Long CJ; Jen M; Canning DA; Weiss DA
    J Pediatr Urol; 2017 Oct; 13(5):490.e1-490.e7. PubMed ID: 28314701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa].
    Saka B; Dzidzinyo K; Akakpo S; Téclessou J; Nouhou Diori A; Maneh N; Mahamadou G; Gnassingbé W; Abilogun-Chokki A; Mouhari-Toure A; Boubacar YA; Kombaté K; Balo K; Tchangai-Walla K; Pitché P
    Ann Dermatol Venereol; 2018 Apr; 145(4):245-249. PubMed ID: 29487020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of ocular involvement in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: french national audit of practices, literature review, and consensus agreement.
    Thorel D; Ingen-Housz-Oro S; Royer G; Delcampe A; Bellon N; Bodemer C; Welfringer-Morin A; Bremond-Gignac D; Robert MP; Tauber M; Malecaze F; Dereure O; Daien V; Colin A; Bernier C; Couret C; Vabres B; Tetart F; Milpied B; Cornut T; Ben Said B; Burillon C; Cordel N; Beral L; de Prost N; Wolkenstein P; Muraine M; Gueudry J
    Orphanet J Rare Dis; 2020 Sep; 15(1):259. PubMed ID: 32962748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.
    De Rojas MV; Dart JK; Saw VP
    Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
    Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
    Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of CD14+ CD16+ monocyte lineage cells in the epidermal damage of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Tohyama M; Watanabe H; Murakami S; Shirakata Y; Sayama K; Iijima M; Hashimoto K
    Br J Dermatol; 2012 Feb; 166(2):322-30. PubMed ID: 21936856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Assessment of Long-Term Complications in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cekic S; Canitez Y; Yuksel H; Ucan Gunduz G; Karali Z; Yalcinbayir O; Vural P; Sapan N
    Int Arch Allergy Immunol; 2023; 184(10):994-1002. PubMed ID: 37494888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular sequelae of epidermal necrolysis: French national audit of practices, literature review and proposed management.
    Thorel D; Ingen-Housz-Oro S; Benaïm D; Daien V; Gabison E; Saunier V; Béral L; Touboul D; Brémond-Gignac D; Robert M; Vasseur R; Royer G; Dereure O; Milpied B; Bernier C; Welfringer-Morin A; Bodemer C; Cordel N; Tauber M; Burillon C; Servant M; Couret C; Vabres B; Tétart F; Cassagne M; Kuoch MA; Muraine M; Delcampe A; Gueudry J
    Orphanet J Rare Dis; 2023 Mar; 18(1):51. PubMed ID: 36906580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases.
    Abe R
    J Dermatol Sci; 2008 Dec; 52(3):151-9. PubMed ID: 18657400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ocular involvement in Stevens-Johnson syndrome: treatment with amniotic membrane transplantation in the acute phase].
    Kardaun SH; Huei Liem K; Stoutenbeek R
    Ned Tijdschr Geneeskd; 2017; 161():D1739. PubMed ID: 29171370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.